Top

Published in:

01-07-2001 | Conference Report

VIP receptor antagonists and chemotherapeutic drugs inhibit the growth of breast cancer cells

Authors: Terry W. Moody, Julius Leyton, Daniel Chan, Douglas C. Brenneman, Mati Fridkin, Edgar Gelber, Albert Levy, Illana Gozes

Published in: Breast Cancer Research and Treatment | Issue 1/2001

Title: VIP receptor antagonists and chemotherapeutic drugs inhibit the growth of breast cancer cells
Authors: Terry W. Moody
Julius Leyton
Daniel Chan
Douglas C. Brenneman
Mati Fridkin
Edgar Gelber
Albert Levy
Illana Gozes
Publication date: 01-07-2001
Publisher: Kluwer Academic Publishers
Published in: Breast Cancer Research and Treatment / Issue 1/2001
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI: https://doi.org/10.1023/A:1017994722130

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 1/2001

Breast cancer in Rubens paintings

The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy

Expression of the nuclear coactivator AIB1 in normal and malignant breast tissue

Tumor characteristics in African American and white women

Breast Cancer Research and Treatment

Solitary breast metastases from a renal cell carcinoma

Keynote webinar | Spotlight on antibody–drug conjugates in cancer